Sofinnova Investments’s Cymabay Therapeutics CBAY Stock Holding History

Sofinnova Investments’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,411,769	Closed	-$33.3M	–	90
2023 Q4	$33.3M	Buy	+1,411,769	New	+$25.1M	1.87%	15

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sofinnova Investments's CBAY Position: Q1 2024 in Review

Sofinnova Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 1,411,769 shares — an estimated $33.3M sold.

Sofinnova Investments first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $33.3M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Sofinnova Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Sofinnova Investments sold 1,411,769 Cymabay Therapeutics shares in Q1 2024, an estimated $33.3M.
Sofinnova Investments first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Sofinnova Investments's Cymabay Therapeutics position peaked at $33.3M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Sofinnova Investments's 13F filing for Q1 2024, filed 15 May 2024.